These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1560386)

  • 21. Phenobarbital pharmacokinetics in rat as a function of age.
    Kapetanovic IM; Sweeney DJ; Rapoport SI
    Drug Metab Dispos; 1982; 10(6):586-9. PubMed ID: 6130904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered pharmacokinetic-pharmacodynamic relationship of heptabarbital in experimental renal failure in rats.
    Dingemanse J; Polhuijs M; Danhof M
    J Pharmacol Exp Ther; 1988 Jul; 246(1):371-6. PubMed ID: 2899167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
    Hoesterey BL; Galinsky RE; Anderson BD
    Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of age on the pharmacodynamics of phenobarbital and ethanol in rats.
    Wanwimolruk S; Levy G
    J Pharm Sci; 1987 Jul; 76(7):503-7. PubMed ID: 3668809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased sensitivity to the anticonvulsant effect of valproate in aging BN/BiRij rats.
    Stijnen AM; Hovinga S; Langemeijer MW; Hoogerkamp A; van Bezooijen CF; Danhof M
    Pharm Res; 1993 Jul; 10(7):1046-51. PubMed ID: 8378246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nutritional status on the pharmacokinetics and pharmacodynamics of pentobarbital.
    Jung D; Prasad PP
    Drug Metab Dispos; 1989; 17(4):365-8. PubMed ID: 2571473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuated function and expression of P-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice.
    Liu H; Zhang D; Xu X; Liu X; Wang G; Xie L; Pang X; Liu L
    Eur J Pharmacol; 2007 Apr; 561(1-3):226-32. PubMed ID: 17349620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
    Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of chlorpromazine on pharmacokinetics and pharmacodynamics of phenobarbital in X-irradiated rats.
    Okulicz-Kozaryn I; Wójciakowa Z; Godlewski J; Nowakowska E
    Pol J Pharmacol Pharm; 1984; 36(1):65-71. PubMed ID: 6462962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of drug action in disease states. XLIII: Potentiating effect of L-tryptophan on the hypnotic action of phenobarbital and ethanol in rats.
    Wilson TC; Levy G
    J Pharm Sci; 1994 Oct; 83(10):1433-6. PubMed ID: 7884665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
    Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
    van Bezooijen CF; van Oorschot RM
    J Pharmacol Exp Ther; 1989 Nov; 251(2):683-6. PubMed ID: 2810117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
    Satterwhite JH; Boudinot FD
    Drug Metab Dispos; 1991; 19(1):61-7. PubMed ID: 1673423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1985 Sep; 234(3):624-8. PubMed ID: 3875710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats.
    Stijnen AM; Postel-Westra I; Langemeijer MW; Hoogerkamp A; Voskuyl RA; van Bezooijen CF; Danhof M
    Br J Pharmacol; 1992 Sep; 107(1):165-70. PubMed ID: 1330159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose methotrexate does not affect the pharmacodynamics of phenobarbital hypnotic action but decreases the central nervous system (CNS) sensitivity to pentylenetetrazol-induced maximal seizures in rats.
    Hoffman A; Alfon J
    Pharm Res; 1992 Oct; 9(10):1295-8. PubMed ID: 1448429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.